Device Trial Radar · NCT01672086
Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System
Last checked: Nov 20, 2026Latest source record: Oct 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
347
Actual
Start
Aug 2012
Primary completion
Jun 2016
Study completion Jun 2016
Sponsor
- Lead sponsor
- StelKast, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 24, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The active surveillance post-approval study of the Stelkast Surpass Acetabular System is a retrospective, multi-center, single-arm study intended to collect data on the survivorship and long-term safety and effectiveness of the device.
Conditions
- Survivorship and Long-term Safety and Effectiveness of the Stelkast Surpass Acetabular System
Interventions
Stelkast Surpass Acetabular System implantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- SurvivorshipTime frame: 10 Years
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Gill Orthopedic Clinic
Charlotte, North Carolina
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.